Dr. Jingwei Chen is a post-doctoral research officer at the Children's Cancer Institute, Sydney, Australia. He graduated from the Univerisity of York, United Kingdom and completed his M.S thesis when he joined Professor Norman Maitland's Lab for adult cancer research at Cancer Research UK in 2015. He expanded his knowledge and research skills in children's cancer and obtained a PhD degree in 2020 from the University of New South Wales, Syndey in the field of pediatric oncology. His current research involves drug discovery, cancer genetics, epigenetics, cancer therapy, RNA methylation, and utilizing patient-derived xenograft (PDX) models to examine the efficacy of anticancer therapies. Ultimately, his work aims to identify molecular aberration underlying cancer progression and harness this information to find novel therapeutic targets and develop novel and targeted therapies for improving patient survival in pediatric cancer.
Best Oral Presentation Awards 2019, AACBS
Early Career Researcher Oral Presentation First Price 2018, Kids Cancer Alliance, Cancer Council New South Wales
The Radhika V. Sreedhar Scholarship 2015